# Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

> **NCT02953327** · PHASE4 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 40 (actual)

## Conditions studied

- Innate Immunity
- Bacille Calmette-Guérin

## Interventions

- **BIOLOGICAL:** Bacille Calmette-Guerin
- **BIOLOGICAL:** BCG solvent

## Key facts

- **NCT ID:** NCT02953327
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-06-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953327, "Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02953327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*